Search Results - "Liver international"

Refine Results
  1. 1

    Liver injury during highly pathogenic human coronavirus infections by Xu, Ling, Liu, Jia, Lu, Mengji, Yang, Dongliang, Zheng, Xin

    Published in Liver international (01-05-2020)
    “…The severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2), the pathogen of 2019 novel coronavirus disease (COVID‐19), has posed a serious threat to…”
    Get full text
    Journal Article
  2. 2

    Comparison of MAFLD and NAFLD diagnostic criteria in real world by Lin, Su, Huang, Jiaofeng, Wang, Mingfang, Kumar, Rahul, Liu, Yuxiu, Liu, Shiying, Wu, Yinlian, Wang, Xiaozhong, Zhu, Yueyong

    Published in Liver international (01-09-2020)
    “…Background and aims Metabolic associated fatty liver disease (MAFLD) is a novel concept proposed in 2020, the utility of which has not been tested and…”
    Get full text
    Journal Article
  3. 3

    Liver impairment in COVID‐19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China by Zhang, Yafei, Zheng, Liang, Liu, Lan, Zhao, Mengya, Xiao, Jun, Zhao, Qiu

    Published in Liver international (01-09-2020)
    “…Background The SARS‐CoV‐2 pandemic is an ongoing global health emergency. The aim of our study was to investigate the changes of liver function and its…”
    Get full text
    Journal Article
  4. 4

    Cholangiocarcinoma: Epidemiology and risk factors by Khan, Shahid A., Tavolari, Simona, Brandi, Giovanni

    Published in Liver international (01-05-2019)
    “…Cholangiocarcinoma (CCA) is a heterogeneous disease arising from a complex interaction between host‐specific genetic background and multiple risk factors…”
    Get full text
    Journal Article
  5. 5

    Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma by Galle, Peter R., Foerster, Friedrich, Kudo, Masatoshi, Chan, Stephen L., Llovet, Josep M., Qin, Shukui, Schelman, William R., Chintharlapalli, Sudhakar, Abada, Paolo B., Sherman, Morris, Zhu, Andrew X.

    Published in Liver international (01-12-2019)
    “…Hepatocellular carcinoma (HCC) is one of the most common causes of cancer‐related deaths globally due, in part, to the majority of patients being diagnosed…”
    Get full text
    Journal Article
  6. 6

    MAFLD identifies patients with significant hepatic fibrosis better than NAFLD by Yamamura, Sakura, Eslam, Mohammed, Kawaguchi, Takumi, Tsutsumi, Tsubasa, Nakano, Dan, Yoshinaga, Shinobu, Takahashi, Hirokazu, Anzai, Keizo, George, Jacob, Torimura, Takuji

    Published in Liver international (01-12-2020)
    “…Background & Aims Diagnostic criteria for metabolic associated fatty liver disease (MAFLD) have been proposed, but not validated. We aimed to compare the…”
    Get full text
    Journal Article
  7. 7

    Pathophysiological mechanisms of liver injury in COVID‐19 by Nardo, Alexander D., Schneeweiss‐Gleixner, Mathias, Bakail, May, Dixon, Emmanuel D., Lax, Sigurd F., Trauner, Michael

    Published in Liver international (01-01-2021)
    “…The recent outbreak of coronavirus disease 2019 (COVID‐19), caused by the Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) has resulted in a…”
    Get full text
    Journal Article
  8. 8

    COVID‐19 and liver disease by Sun, Jian, Aghemo, Alessio, Forner, Alejandro, Valenti, Luca

    Published in Liver international (01-06-2020)
    “…Since December 2019, patients with unexplained pneumonia have been found in Wuhan, Hubei Province, China, which was caused by a novel coronavirus that had not…”
    Get full text
    Journal Article
  9. 9

    Changing epidemiology of hepatocellular carcinoma in Asia by Zhang, Chen‐hao, Cheng, Yifei, Zhang, Shu, Fan, Jia, Gao, Qiang

    Published in Liver international (01-08-2022)
    “…Liver cancer is the fifth most common cancer and the second leading cause of malignant death in Asia, and Asia reports 72.5% of the world's cases in 2020. As…”
    Get full text
    Journal Article
  10. 10

    Clinical characteristics of non‐ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study by Xie, Hansheng, Zhao, Jianming, Lian, Ningfang, Lin, Su, Xie, Qunfang, Zhuo, Huichang

    Published in Liver international (01-06-2020)
    “…Background & Aims Coronavirus disease 2019 (COVID‐19) has raised world concern for global epidemic since December, 2019. Limited data are available for liver…”
    Get full text
    Journal Article
  11. 11

    What's in a name? Renaming ‘NAFLD’ to ‘MAFLD’ by Fouad, Yasser, Waked, Imam, Bollipo, Steven, Gomaa, Ahmed, Ajlouni, Yousef, Attia, Dina

    Published in Liver international (01-06-2020)
    “…In medicine, language matters and the words used to name and describe a disease can have a profound impact on patients and their families. Over the last two…”
    Get full text
    Journal Article
  12. 12

    Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations by Sonzogni, Aurelio, Previtali, Giulia, Seghezzi, Michela, Grazia Alessio, Maria, Gianatti, Andrea, Licini, Lisa, Morotti, Denise, Zerbi, Pietro, Carsana, Luca, Rossi, Roberta, Lauri, Eleonora, Pellegrinelli, Alessandro, Nebuloni, Manuela

    Published in Liver international (01-09-2020)
    “…SARS2‐CoV‐2 breakout in Italy caused a huge number of severely ill patients with a serious increase in mortality. Although lungs seem to be the main target of…”
    Get full text
    Journal Article
  13. 13

    Prognostic accuracy of FIB‐4, NAFLD fibrosis score and APRI for NAFLD‐related events: A systematic review by Lee, Jenny, Vali, Yasaman, Boursier, Jerome, Spijker, Rene, Anstee, Quentin M., Bossuyt, Patrick M., Zafarmand, Mohammad H.

    Published in Liver international (01-02-2021)
    “…Background & Aims Fibrosis is the strongest predictor for long‐term clinical outcomes among patients with non‐alcoholic fatty liver disease (NAFLD). There is…”
    Get full text
    Journal Article
  14. 14

    Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms by Dar, Wasim A., Sullivan, Elise, Bynon, John S., Eltzschig, Holger, Ju, Cynthia

    Published in Liver international (01-05-2019)
    “…Liver disease causing end organ failure is a growing cause of mortality. In most cases, the only therapy is liver transplantation. However, liver…”
    Get full text
    Journal Article
  15. 15

    Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study by Park, Joong-Won, Chen, Minshan, Colombo, Massimo, Roberts, Lewis R., Schwartz, Myron, Chen, Pei-Jer, Kudo, Masatoshi, Johnson, Philip, Wagner, Samuel, Orsini, Lucinda S., Sherman, Morris

    Published in Liver international (01-09-2015)
    “…Background & Aims Hepatocellular carcinoma (HCC) is the second most common cause of cancer deaths worldwide. The global HCC BRIDGE study was a multiregional,…”
    Get full text
    Journal Article
  16. 16

    Liver diseases: A major, neglected global public health problem requiring urgent actions and large‐scale screening by Marcellin, Patrick, Kutala, Blaise K.

    Published in Liver international (01-02-2018)
    “…CLDs represent an important, and certainly underestimated, global public health problem. CLDs are highly prevalent and silent, related to different, sometimes…”
    Get full text
    Journal Article
  17. 17

    Anatomical, histomorphological and molecular classification of cholangiocarcinoma by Kendall, Timothy, Verheij, Joanne, Gaudio, Eugenio, Evert, Matthias, Guido, Maria, Goeppert, Benjamin, Carpino, Guido

    Published in Liver international (01-05-2019)
    “…Cholangiocarcinoma constitutes a heterogeneous group of malignancies that can emerge at any point of the biliary tree. Cholangiocarcinoma is classified into…”
    Get full text
    Journal Article
  18. 18

    The epidemiology of non‐alcoholic fatty liver disease by Bellentani, Stefano

    Published in Liver international (01-01-2017)
    “…The increase in Non‐alcoholic Fatty Liver Disease (NAFLD) and the imminent disappearance of chronic viral hepatitis thanks to new and effective therapies is…”
    Get full text
    Journal Article
  19. 19

    Surgery for cholangiocarcinoma by Cillo, Umberto, Fondevila, Constantino, Donadon, Matteo, Gringeri, Enrico, Mocchegiani, Federico, Schlitt, Hans J., Ijzermans, Jan N. M., Vivarelli, Marco, Zieniewicz, Krzysztof, Olde Damink, Steven W. M., Groot Koerkamp, Bas

    Published in Liver international (01-05-2019)
    “…Surgical resection is the only potentially curative treatment for patients with cholangiocarcinoma. For both perihilar cholangiocarcinoma (pCCA) and…”
    Get full text
    Journal Article
  20. 20

    Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population by Ciardullo, Stefano, Perseghin, Gianluca

    Published in Liver international (01-06-2021)
    “…Data are limited on the epidemiological implications of the recent change in terminology from nonalcoholic fatty liver disease (NAFLD) to metabolic…”
    Get full text
    Journal Article